1. Home
  2. ACET vs IPWR Comparison

ACET vs IPWR Comparison

Compare ACET & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

N/A

Current Price

$7.68

Market Cap

69.6M

Sector

Health Care

ML Signal

N/A

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

N/A

Current Price

$3.35

Market Cap

39.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ACET
IPWR
Founded
1947
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
69.6M
39.9M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
ACET
IPWR
Price
$7.68
$3.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$65.33
$10.75
AVG Volume (30 Days)
161.1K
84.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
59.82
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3,233.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$2.62
52 Week High
$9.05
$6.90

Technical Indicators

Market Signals
Indicator
ACET
IPWR
Relative Strength Index (RSI) 57.76 46.04
Support Level $7.70 $2.91
Resistance Level $8.46 $4.35
Average True Range (ATR) 0.46 0.37
MACD -0.01 0.01
Stochastic Oscillator 96.30 43.73

Price Performance

Historical Comparison
ACET
IPWR

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: